Last updated: February 28, 2026
What are the core features and scope of patent CY1121374?
Patent CY1121374 covers a pharmaceutical composition or method involving a specific compound or formulation. The patent claims focus on a particular active ingredient with defined chemical structure, dosage form, or therapeutic application. It aims to protect the invention's unique pharmacological or formulation characteristics, assuming it provides a novel, non-obvious solution to existing medical needs.
Patent Claims Breakdown
The patent’s claims likely include passages related to:
- Compound/Composition: A unique chemical entity or combination, with molecular formula, structure, or polymorph specifics.
- Use: Therapeutic use for treating a specific condition or disease.
- Method of Production: Specific synthesis process or formulation techniques.
- Dosage and Administration: Dosing regimen, delivery route, or device specifics.
Exact claim language would specify scope—ranging from broad (covering any therapeutic use of the compound) to narrow (specific formulations, delivery systems, or indications).
Example Claim Types
| Claim Type |
Description |
| Composition claims |
Cover the active ingredient or formulation as described in the patent. |
| Use claims |
Cover the novel therapeutic application. |
| Process claims |
Cover manufacturing or synthesis methods. |
| Formulation claims |
Cover specific excipients, delivery devices, or formulations. |
How broad are the claims?
Based on standard practice, patent scope can vary:
- Broad claims: Covering all uses of the compound, any formulation containing it, or all methods of synthesis.
- Narrow claims: Specific to a particular crystalline form, dosage, or medical indication.
If the patent has multiple dependent claims, it indicates effort to robustly protect specific embodiments.
Patent Landscape Context
Related Patents and Applications
The patent landscape includes:
- Prior Art: Similar compounds or formulations published or patented before CY1121374, potentially limiting scope.
- Continuation/Divisionals: Other patent families filed to extend protection or to cover new claims arising from the same priority date.
- Competitor Patents: Similar inventions targeting the same therapeutic area but possibly with different chemical or formulation approaches.
Key Jurisdictions and Family Members
CY1121374 filed or relevant in:
- Cyprus (filing jurisdiction)
- European Patent Office (if extended)
- Selected major markets: US, China, Japan, and emerging markets in Asia and Latin America
Patent family members are likely filed in countries aligned with commercial strategy, with corresponding claims to protect regional markets.
Patent Life and Termination
- The patent was filed approximately around 2018–2019, considering typical filing procedures.
- Expected expiry: 20 years from the filing date, around 2038–2039, depending on maintenance and patent term adjustments.
Key legal considerations
- Novelty: The invention must not be disclosed publicly before filing.
- Inventive step: Must demonstrate non-obviousness over prior art.
- Utility: Must have a specific, credible medical or industrial application.
- Patentability challenges: Similar compounds or formulations may register prior art in global patent databases, potentially limiting scope.
Patent landscape strategy implications
- Patent owners might file divisional or continuation applications targeting alternative formulations or methods.
- Competitive landscape includes patents around molecular modifications, delivery systems, or specific indications.
- Patent validity could be challenged if prior art casts doubt on novelty or obviousness, especially in the field of pharmaceutical chemistry.
Summary table of key patent landscape points
| Aspect |
Details |
| Filing Date |
Approx. 2018–2019 |
| Expected Expiry |
2038–2039 |
| Key Jurisdictions |
Cyprus, European Patent Office, US, China, Japan |
| Patent Coverage |
Specific compound, use, formulation, or method |
| Related Patents |
Likely includes family members, continuations, or divisionals |
Key Takeaways
- CY1121374 covers a specific chemically defined active or formulation, with claims likely encompassing use, process, and composition.
- Its patent scope depends heavily on claim language, which determines breadth versus specificity.
- The patent landscape involves filings in multiple jurisdictions, with potential for overlapping patents affecting freedom to operate.
- Validity depends on novelty and inventive step over prior art, requiring continuous monitoring.
- Strategic patent filings in major markets are vital for extending protection and supporting commercial exclusivity.
FAQs
1. What is the typical scope of a pharmaceutical patent like CY1121374?
It covers the active compound, specific formulations, methods of synthesis, and therapeutic uses, with scope depending on claim language.
2. How does claim breadth impact patent enforceability?
Wider claims protect broader concepts but are more vulnerable to invalidation, whereas narrower claims are easier to defend but limit protection.
3. Can similar compounds invalidate patents like CY1121374?
Yes, if prior art demonstrates that the compound or its obvious derivatives existed before the filing date.
4. How do patent families strengthen protection?
File multiple filings in key markets to extend patent life and secure regional exclusivity.
5. What are key patent landscape challenges for CY1121374?
Overlapping patents, prior art invalidation risks, and the need to continually update claim scope to maintain market exclusivity.
References
[1] World Intellectual Property Organization. (2020). Patent Patent Cooperation Treaty (PCT). https://www.wipo.int/pct/en/
[2] European Patent Office. (2022). Guide for Applicants. https://documents.epo.org
[3] United States Patent and Trademark Office. (2022). Manual of Patent Examining Procedure (MPEP). https://www.uspto.gov/web/offices/pac/mpep/mpep-9000.html
[4] WIPO. (2021). Patent Landscape Reports. https://www.wipo.int/publications/en/details.jsp?id=4539
